Xponance Inc. Cuts Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Xponance Inc. decreased its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 5.8% during the second quarter, Holdings Channel.com reports. The firm owned 11,601 shares of the company’s stock after selling 709 shares during the period. Xponance Inc.’s holdings in HealthEquity were worth $1,000,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the business. Motley Fool Asset Management LLC boosted its holdings in shares of HealthEquity by 3,001.0% in the 1st quarter. Motley Fool Asset Management LLC now owns 3,762,064 shares of the company’s stock worth $307,097,000 after purchasing an additional 3,640,748 shares during the period. Vaughan Nelson Investment Management L.P. purchased a new position in HealthEquity during the first quarter worth $49,443,000. Wasatch Advisors LP increased its position in HealthEquity by 8.3% during the first quarter. Wasatch Advisors LP now owns 7,409,080 shares of the company’s stock valued at $604,803,000 after acquiring an additional 569,249 shares during the last quarter. Generate Investment Management Ltd purchased a new stake in shares of HealthEquity in the second quarter valued at $24,184,000. Finally, Goldman Sachs Group Inc. lifted its holdings in shares of HealthEquity by 24.7% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,129,634 shares of the company’s stock worth $74,895,000 after acquiring an additional 223,428 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

Insider Activity

In related news, Director Frank Corvino sold 7,705 shares of the company’s stock in a transaction on Monday, July 8th. The stock was sold at an average price of $81.89, for a total transaction of $630,962.45. Following the completion of the sale, the director now directly owns 6,070 shares in the company, valued at approximately $497,072.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Frank Corvino sold 7,705 shares of HealthEquity stock in a transaction that occurred on Monday, July 8th. The shares were sold at an average price of $81.89, for a total value of $630,962.45. Following the transaction, the director now owns 6,070 shares of the company’s stock, valued at approximately $497,072.30. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Vice Chairman Stephen Neeleman sold 35,000 shares of the stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the sale, the insider now directly owns 89,769 shares of the company’s stock, valued at approximately $7,168,952.34. The disclosure for this sale can be found here. Company insiders own 2.20% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. JMP Securities reiterated a “market outperform” rating and set a $105.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. Barrington Research reiterated an “outperform” rating and issued a $105.00 price target on shares of HealthEquity in a report on Friday, September 20th. Robert W. Baird boosted their price objective on HealthEquity from $98.00 to $104.00 and gave the company an “outperform” rating in a report on Tuesday, June 4th. Bank of America cut their price objective on HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, September 4th. Finally, Raymond James lifted their target price on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Friday, June 7th. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, HealthEquity has an average rating of “Moderate Buy” and an average target price of $103.83.

HealthEquity Stock Up 1.6 %

NASDAQ:HQY opened at $79.93 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. The firm has a market cap of $6.95 billion, a PE ratio of 86.88, a price-to-earnings-growth ratio of 1.25 and a beta of 0.52. The company has a 50-day moving average of $76.29 and a 200 day moving average of $79.24. HealthEquity, Inc. has a 1-year low of $61.81 and a 1-year high of $88.26.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.16. The firm had revenue of $299.93 million for the quarter, compared to the consensus estimate of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. As a group, research analysts anticipate that HealthEquity, Inc. will post 2.25 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.